CNR Institutional Research Information System

MANCA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.224
NA - Nord America 1.031
EU - Europa 631
SA - Sud America 373
AF - Africa 38
OC - Oceania 5
Totale 4.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 980
SG - Singapore 964
CN - Cina 455
BR - Brasile 306
HK - Hong Kong 247
IT - Italia 224
VN - Vietnam 217
FR - Francia 118
JP - Giappone 99
NL - Olanda 97
KR - Corea 65
IN - India 46
DE - Germania 45
GB - Regno Unito 38
BD - Bangladesh 32
AR - Argentina 26
CA - Canada 23
FI - Finlandia 22
ID - Indonesia 18
MX - Messico 17
AT - Austria 14
ZA - Sudafrica 14
IE - Irlanda 13
IL - Israele 12
IQ - Iraq 12
PL - Polonia 9
VE - Venezuela 9
EC - Ecuador 8
ES - Italia 8
PH - Filippine 8
SA - Arabia Saudita 8
UY - Uruguay 7
CO - Colombia 6
KE - Kenya 6
RU - Federazione Russa 6
TR - Turchia 6
MA - Marocco 5
PY - Paraguay 5
UZ - Uzbekistan 5
DZ - Algeria 4
KZ - Kazakistan 4
PE - Perù 4
PK - Pakistan 4
AU - Australia 3
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
NP - Nepal 3
OM - Oman 3
SE - Svezia 3
TN - Tunisia 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.302
Salva come PNG Salva come JPEG
Città #
Singapore 530
Santa Clara 292
Hong Kong 245
Hefei 137
San Jose 134
Lauterbourg 96
Beijing 93
Tokyo 87
Ashburn 84
Ho Chi Minh City 75
Hanoi 64
Seoul 62
Los Angeles 59
Dallas 47
São Paulo 26
Cavallino 22
New York 21
Cagliari 17
Amsterdam 15
Guangzhou 14
Council Bluffs 13
Dublin 13
Frankfurt am Main 12
Rome 12
Helsinki 11
Milan 11
Orem 11
Rio de Janeiro 11
Buffalo 10
Düsseldorf 10
Vienna 10
Minamishinagawa 9
Genoa 8
Montreal 8
Naples 8
Phoenix 8
Turku 8
Florence 7
Nuremberg 7
Sala Baganza 7
Assemini 6
Belo Horizonte 6
Bengaluru 6
Brooklyn 6
Campinas 6
Chennai 6
Da Nang 6
Hải Dương 6
Jakarta 6
Johannesburg 6
Manchester 6
Montevideo 6
Mumbai 6
Munich 6
Nairobi 6
Thái Nguyên 6
Bari 5
Boardman 5
Denver 5
Maceió 5
Sassari 5
Tashkent 5
Warsaw 5
Baghdad 4
Biên Hòa 4
Boston 4
Curitiba 4
Elk Grove Village 4
Haiphong 4
Houston 4
Hyderabad 4
London 4
Porto Alegre 4
Quận Một 4
Recife 4
Riyadh 4
Salvador 4
Seattle 4
Toronto 4
Uberlândia 4
Buenos Aires 3
Cape Town 3
Carapicuíba 3
Chicago 3
Dhaka 3
Franca 3
Goiânia 3
Guarulhos 3
Guayaquil 3
Ha Long 3
Hortolândia 3
Lappeenranta 3
Madrid 3
Marseille 3
Mexico City 3
Montes Claros 3
Nanjing 3
New Delhi 3
Newark 3
Paranaque City 3
Totale 2.573
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 92
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 78
Il CSCC: aspetti distintivi della patologia 76
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 73
Germline and somatic NGS-based analysis on BRCA-related tumors 72
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 69
Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the “AMICA” project 69
nalysis of Fanconi anemia genes in colorectal cancer. 65
Idiopathic pulmonary fibrosis (IPF) and lung cancer 65
Molecular Basis of open-angle glaucoma in Italy 64
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 63
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 63
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 63
Phenotype characterization of human melanoma cells resistant to Dabrafenib 62
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Genetic Instability Markers in Cancer 59
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 59
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Genetic alterations in main candidate genes during melanoma progression. 56
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 54
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 50
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 48
Ngs-based analysis of atypical deep penetrating nevi 48
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 48
Origin of aneuploidy in relation to disturbances of cell-cycle progression. I. Effects of vinblastine on mouse bone marrow cells 46
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 43
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 41
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 41
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome 40
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 40
Proteomic analysis in melanoma cell lines with different genotypes 39
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 39
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 38
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 37
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 35
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 35
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 35
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 34
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 34
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 34
Long non-coding RNA CASC2 in human cancer 34
Proteomic Profiling of Human Melanoma Metastatic Cell Line Secretomes 33
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 33
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 33
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 32
Low prevalence of microsatellite instability in malignant melanoma. 30
Molecular basis of open-angle glaucoma in Italy 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
Assesment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 30
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 30
Genetic alterations in main candidate genes during melanoma progression 30
Detailed physical analysis of a 1.5-megabase YAC contig containing the MXI1 and ADRA2A genes 29
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 29
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 29
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 29
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 29
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 28
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 28
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 27
Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad 27
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 27
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 27
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 26
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases 26
Discrepant alterations in main candidate genes among multiple primary melanomas 26
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 26
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 26
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 26
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 25
Assessment of the progressive alterations in hepathic tumorigenesis through metabolic analysis. 25
Downregulation of the CASC2a gene in endometrial cancer. 25
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
MUTATIONS IN ERBB4 MAY PLAY A MINOR ROLE IN MELANOMA PATHOGENESIS 25
Fragile X syndrome without CCG amplification has an FMR1 deletion 25
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 24
A strategy for the selection of transcribed sequences in the Xq28 region 24
Epidemiological and genetic factors underlying melanoma development in Italy 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Role on the BRAF gene in malignant melanoma 24
Proteomics and expression analysis for identification of new candidate genes in melanoma progression 23
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 23
Cytogenetic assesment of the involvement of a new locus at 9p21 in malignant melanoma. 23
TRANSGENIC MOUSE - AN INVIVO SYSTEM FOR DETECTION OF ANEUGENS 23
Progressive alterations at chromosome 9P21 in melanomagenesis 23
Role of CASC2 a gene in human endometrial cancer. 23
Totale 4.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.507
article - articoli 11.264
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 716
Totale 26.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 5 0 15 8
2024/20251.631 17 6 98 64 294 77 29 98 66 100 382 400
2025/20262.749 137 201 261 337 512 124 476 174 207 185 135 0
Totale 4.408